In October 2015, Anna Huttenlocher, MD, was elected to the National Academy of Medicine (NAM), a prestigious role in which she will provide expert scientific advice to the nation to help shape policies, inform public opinion and advance the pursuit of science, engineering and medicine.
Dr. Huttenlocher is a practicing pediatric rheumatologist who is recognized internationally for her pioneering studies of cell migration and alterations of cell migration in human diseases.
She was trained at Harvard Medical School, Boston Children's Hospital, and the University of California-San Francisco. She joined the Department of Pediatrics faculty in 1999, and in 2006 moved her basic research lab to the Department of Medical Microbiology and Immunology.
In the summer of 2012, she became the director of the UW School of Medicine and Public Health’s Medical Scientist Training Program, which combines a medical education and PhD-level graduate research training.
Ned Kalin, MD, chair of the UW Department of Psychiatry, was also elected to the NAM at the same time as Dr. Huttenlocher.
UW SMPH Dean Robert Golden, MD, said that Drs. Huttenlocher and Kalin “represent the finest qualities of our faculty – creativity and innovation in science, dedication to teaching and mentoring, and a deep-rooted commitment to service.” (Read related story)
The National Academy of Medicine was originally the Institute of Medicine, which was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected to the National Academy of Medicine by their peers for distinguished contributions to medicine and health.